- Forums
- ASX - By Stock
- MSB
- Ann: Remestemcel Clinical and Potency Studies Presented at Tandem
Ann: Remestemcel Clinical and Potency Studies Presented at Tandem, page-216
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.02 |
Change
0.018(1.74%) |
Mkt cap ! $1.153B |
Open | High | Low | Value | Volume |
$1.00 | $1.04 | 94.0¢ | $10.43M | 10.60M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
16 | 59514 | $1.02 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.03 | 19180 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 123 | 1.025 |
17 | 86089 | 1.020 |
13 | 129860 | 1.015 |
12 | 201550 | 1.010 |
12 | 534165 | 1.005 |
Price($) | Vol. | No. |
---|---|---|
1.030 | 221587 | 29 |
1.035 | 143778 | 20 |
1.040 | 106218 | 11 |
1.045 | 127842 | 8 |
1.050 | 37412 | 5 |
Last trade - 15.17pm 31/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, CEO
Anthony Noble
CEO
SPONSORED BY The Market Online